Charles Schwab’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-375,239
Closed -$14.4M 3687
2023
Q2
$14.4M Sell
375,239
-2,888
-0.8% -$111K ﹤0.01% 1709
2023
Q1
$8.75M Sell
378,127
-5,585
-1% -$129K ﹤0.01% 1935
2022
Q4
$10.1M Buy
383,712
+9,225
+2% +$242K ﹤0.01% 1849
2022
Q3
$7.36M Buy
374,487
+215,075
+135% +$4.23M ﹤0.01% 2007
2022
Q2
$2.79M Buy
159,412
+47,937
+43% +$839K ﹤0.01% 2448
2022
Q1
$1.82M Buy
111,475
+9,374
+9% +$153K ﹤0.01% 2674
2021
Q4
$1.67M Buy
102,101
+17,501
+21% +$286K ﹤0.01% 2757
2021
Q3
$1.08M Buy
84,600
+4,609
+6% +$58.8K ﹤0.01% 2848
2021
Q2
$1.13M Buy
79,991
+38,774
+94% +$548K ﹤0.01% 2887
2021
Q1
$641K Buy
41,217
+19
+0% +$295 ﹤0.01% 3003
2020
Q4
$654K Buy
41,198
+7,583
+23% +$120K ﹤0.01% 2901
2020
Q3
$409K Sell
33,615
-1,412
-4% -$17.2K ﹤0.01% 2936
2020
Q2
$405K Buy
35,027
+7,386
+27% +$85.4K ﹤0.01% 2913
2020
Q1
$379K Sell
27,641
-2,293
-8% -$31.4K ﹤0.01% 2803
2019
Q4
$177K Buy
29,934
+3,854
+15% +$22.8K ﹤0.01% 3053
2019
Q3
$139K Sell
26,080
-35,136
-57% -$187K ﹤0.01% 3077
2019
Q2
$472K Buy
61,216
+2,233
+4% +$17.2K ﹤0.01% 2836
2019
Q1
$1.17M Buy
58,983
+3,635
+7% +$72.4K ﹤0.01% 2513
2018
Q4
$731K Sell
55,348
-3,667
-6% -$48.4K ﹤0.01% 2634
2018
Q3
$2.17M Buy
59,015
+12,345
+26% +$454K ﹤0.01% 2405
2018
Q2
$1.63M Buy
46,670
+13,856
+42% +$485K ﹤0.01% 2433
2018
Q1
$1.53M Buy
32,814
+2,972
+10% +$138K ﹤0.01% 2411
2017
Q4
$1.12M Sell
29,842
-5,054
-14% -$190K ﹤0.01% 2476
2017
Q3
$1.86M Buy
34,896
+1,828
+6% +$97.4K ﹤0.01% 2316
2017
Q2
$1.89M Buy
33,068
+4,046
+14% +$231K ﹤0.01% 2241
2017
Q1
$1.56M Buy
29,022
+1,562
+6% +$84K ﹤0.01% 2280
2016
Q4
$1.57M Buy
27,460
+1,469
+6% +$83.8K ﹤0.01% 2275
2016
Q3
$1.62M Buy
25,991
+12,877
+98% +$801K ﹤0.01% 2236
2016
Q2
$742K Buy
13,114
+8,727
+199% +$494K ﹤0.01% 2448
2016
Q1
$281K Buy
4,387
+82
+2% +$5.25K ﹤0.01% 2796
2015
Q4
$606K Buy
4,305
+104
+2% +$14.6K ﹤0.01% 2560
2015
Q3
$407K Buy
4,201
+266
+7% +$25.8K ﹤0.01% 2701
2015
Q2
$597K Buy
+3,935
New +$597K ﹤0.01% 2616